Tomosynthesis cuts interval breast cancers by a quarter in major screening trial
The TOSYMA trial of nearly 100,000 women found that digital breast tomosynthesis reduced invasive interval breast cancers by 29 percent ...
The TOSYMA trial of nearly 100,000 women found that digital breast tomosynthesis reduced invasive interval breast cancers by 29 percent ...
Every year, tens of millions of mammograms are performed worldwide, and many of them contain a quiet clue about a ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.